Document text
Principal Investigator: Susan Napier Thomas
Organization: GORDON RESEARCH CONFERENCES
Fiscal Year: 2024
Award: $9,000
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary/Abstract
Immunoengineering is a vibrant, emerging field that improves human health by enabling the analysis,
manipulation, and engineering of the immune system. Grounded in fundamental immunology discoveries, the
integration of principles from engineering and the physical sciences into immunological research has accelerated
in the last decade. However, the immunoengineering community until recently did not have a flagship conference
that brings together all of its constituencies. Workshops held at individual universities and symposia within larger
conferences have been well attended, but an internationally accessible conference that supports networking
between generations of researchers and across fields has been missing. Such a conference is needed to bring
together leaders, new investigators, and trainees from different disciplines for the first time, to advance both
translational and fundamental science and to provide a focal point for collaborative relationships, career guidance,
and mentoring of trainees in this field. Therefore, this proposal requests partial support for the second
international meeting on Immunoengineering as part of the Gordon Research Conference (GRC) and Gordon
Research Seminar (GRS) series, to be held in Lucca, Italy February 10-11 (GRS) & 11 – 16 (GRC), 2024. The
specific aims of the conference are (i) to increase knowledge in immunoengineering at two levels – basic as
well as translational immunotherapy and immunology – by promoting engagement between investigators from
different disciplines, (ii) to advance the careers of new investigators and trainees in field of Immunoengineering
by showcasing their work and facilitating networking with senior investigators and peer mentors, and (iii) to
enhance diversity, equity, and inclusion among new investigators and trainees in Immunoengineering via strong
representation at the meeting. The GRC program will have a keynote address and nine sessions that broadly
address pressing health challenges where immunoengineering is making substantial headway in or already has
had translational impact, including cancer, pathogens, aging, neuroimmunology and autoimmunity, and
regenerative medicine. It will also highlight engineered immune cell therapies, molecularly engineered
immunotherapies, biomaterials for vaccines and immunomodulation, systems and computational immunology,
in vitro models of immunity, and micro-technologies to assess immune cell function. Each session will feature 1-
2 Short Talks selected from abstracts to highlight work by early stage investigators, as well as poster sessions
and an innovative lunch-based networking strategy. The Chairs of the GRC will implement strategies to increase
participation of woman and historically underrepresented minorities by setting aside specific funding for such
individuals, targeted advertising, and ensuring that they are well represented in the Short Talks. Thus, the 2024
Immunoengineering GRC and GRS will set the stage for the advancement of knowledge and translation in
Immunoengineering by promoting engagement and long-term relationships across fields, while supporting a
diverse base of young investigators to ensure its future strength.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Academia><Acceleration><Address><Advertising><Aging><Allergy><Autoimmune Status><Autoimmunity><Bi-specific antibodies><Bifunctional Antibodies><Biocompatible Materials><Biomaterials><Bispecific Antibodies><CAR T cells><CAR modified T cells><CAR-T><CAR-Ts><COVID-19 virus><COVID19 virus><Cancer Treatment><Cancers><Cardiac Diseases><Cardiac Disorders><Career Counseling><Career Guidance><Career Mobility><Cell Body><Cell Function><Cell Physiology><Cell Process><Cells><Cellular Function><Cellular Physiology><Cellular Process><Cellular immunotherapy><Clinic><Clinical><CoV-2><CoV2><Collaborations><Communities><Discipline><Disease Progression><Disparate><Ebola><Educational workshop><Engineering><Ensure><Equity><Event><Fostering><Foundations><Funding><Future><Generations><Health><Heart Diseases><Human><Hypersensitivity><Immune><Immune mediated therapy><Immune response><Immunes><Immunity><Immunochemical Immunologic><Immunologic><Immunological><Immunological response><Immunologically><Immunologically Directed Therapy><Immunologics><Immunologist><Immunology><Immunomodulation><Immunotherapy><Individual><Industry><Infection><International><Investigators><Italy><Journals><Knowledge><Leadership><Magazine><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mentors><Modern Man><Molecular><Names><Nature><Nerve Degeneration><Neuron Degeneration><Nucleic Acids><Occupational Guidance><Position><Positioning Attribute><RNA vaccine><RNA-based vaccine><Regenerative Medicine><Request for Proposals><Research><Research Personnel><Researchers><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Science><Scientist><Series><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Subcellular Process><Suggestion><System><T cells for CAR><Technology><Testing><Therapeutic><Time><Translations><Underrepresented Ethnic Minority><Underrepresented Minority><Universities><Vaccines><Vocational Counseling><Vocational Guidance><Woman><Work><Workshop><Wuhan coronavirus><anti-cancer immunotherapy><anti-cancer therapy><anticancer immunotherapy><base><bases><biological material><bsAb><cancer immunotherapy><cancer therapy><cancer-directed therapy><career><career advancement><career counselor><career transition><cell-based immunotherapy><chimeric antigen T cell receptor><chimeric antigen receptor (CAR) T cells><chimeric antigen receptor T cells><chimeric antigen receptor fusion protein T-cells><chimeric antigen receptor modified T cells><clinical care><conference><convention><coronavirus disease 2019 virus><coronavirus disease-19 virus><design><designing><diversity and inclusion><diversity and inclusivity><diversity, equity, and inclusiveness><engineered immune system><equity, diversity, and inclusion><executive coaching><fighting><global health><hCoV19><heart disorder><host response><immune cell therapy><immune engineering><immune modulation><immune regulation><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immuno therapy><immunoengineering><immunologic reactivity control><immunomodulatory><immunoneurology><immunoregulation><immunoregulatory><immunoresponse><immunotherapy for cancer><immunotherapy of cancer><improved><in vitro Model><innovate><innovation><innovative><interdisciplinary approach><interdisciplinary collaboration><mRNA vaccine><mRNA-based vaccine><malignancy><meeting><meetings><multidisciplinary approach><nCoV2><name><named><naming><neoplasm/cancer><neural degeneration><neural inflammation><neurodegeneration><neurodegenerative><neuroimmunology><neuroinflammation><neuroinflammatory><neurological degeneration><neuronal degeneration><new approaches><new vaccines><next generation vaccines><novel approaches><novel strategies><novel strategy><novel vaccines><pathogen><peer><peer coaching><peer instruction><peer led team learning><peer mentoring><peer teaching><physical science><posters><prevent><preventing><professor><programs><success><summit><support network><symposia><symposium><transdisciplinary collaboration><translation><translational impact><under-representation of minorities><under-represented minority><underrepresentation of minorities>